Audited Results of Concord Biotech Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Operating Income	1,055.07	1,200.09	1,016.94	853.17
Manufacturing Expenses	116.20	112.23	104.97	97.65
Personnel Expenses	170.19	138.93	123.05	110.28
Selling Expenses	0	0	0	0
Administrative Expenses	131.87	124.89	115.76	108.68
Expenses Capitalised	0	0	0	0
Cost Of Sales	678.54	693.76	585.38	509.88
Operating Profit	376.54	506.33	431.56	343.29
Other Recurring Income	52.73	44.45	33.78	35.31
Adjusted PBDIT	429.27	550.78	465.34	378.60
Financial Expenses	0.23	0.53	2.55	4.51
Depreciation	74.33	54.37	53.59	54.03
Other Write offs	0	0	0	0
Adjusted PBT	354.71	495.88	409.19	320.05
Tax Charges	88.17	122.91	104.46	81.93
Adjusted PAT	266.54	372.96	304.73	238.13
Non Recurring Items	52.50	5.97	-0.01	0.26
Other Non Cash adjustments	0	0	0	0
Reported Net Profit	263.27	372.96	304.73	238.13
Equity Dividend	111.94	91.54	71.45	53.56
Preference Dividend	0	0	0	0
Retained Earnings	1,898.10	1,691	1,403.60	1,170.33

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article